C4XD Insider Trading

Insider Ownership Percentage: 27.13%
Insider Buying (Last 12 Months): £48,532
Insider Selling (Last 12 Months): GBX 0

C4X Discovery Insider Trading History Chart

This chart shows the insider buying and selling history at C4X Discovery by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

C4X Discovery Share Price & Price History

Current Price: GBX 12
Price Change: Price Increase of +2.575 (27.32%)
As of 04/25/2024 10:20 PM ET

This chart shows the closing price history over time for C4XD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

C4X Discovery Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/8/2024Clive DixInsiderBuy485,320GBX 10£48,532
See Full Table

SEC Filings (Institutional Ownership Changes) for C4X Discovery (LON:C4XD)

52.12% of C4X Discovery stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

C4X Discovery logo
C4X Discovery Holdings plc operates as drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing 4D molecules in virtual reality research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules. Its product pipeline includes Orexin-1, a receptor antagonist for the treatment of addictive disorders; NRF-2 activator to treat various inflammatory diseases; IL-17A inhibitor for inflammation diseases; a4ß7 integrin inhibitors for the treatment of inflammatory bowel disease; and MALT-1 inhibitors to treat hematological cancer. The company was formerly known as Schosween 24 plc and changed its name to C4X Discovery Holdings plc October 2014. C4X Discovery Holdings plc was incorporated in 2007 and is based in Manchester, the United Kingdom.
Read More on C4X Discovery

Today's Range

Now: GBX 12
Low: 8.30
High: 12

50 Day Range

MA: GBX 12
Low: 12
High: 12

52 Week Range

Now: GBX 12
Low: 7
High: 22

Volume

3,770,459 shs

Average Volume

1,183,176 shs

Market Capitalization

£30.27 million

P/E Ratio

300.00

Dividend Yield

N/A

Beta

0.23

Who are the company insiders with the largest holdings of C4X Discovery?

C4X Discovery's top insider investors include:
  1. Clive Dix (Insider)
Learn More about top insider investors at C4X Discovery.